Essential psychiatric medicines: wrong selection, high consumption and social problems

BMC Public Health
Izabela FuloneLuciane Cruz Lopes

Abstract

The World Health Organization Essential Medicines List (WHO-LIST) and national essential medicines lists differ because many countries face significant challenges, such as product availability, cost, product quality and epidemiological disease profiles. In Brazil, governments pay for drugs that are included on the federal, state and municipal government (REMUME) lists. The extent to which municipal lists differ from state and national lists and from the WHO-LIST is unclear. We investigate the use of the WHO-LISTas a tool with which to evaluate the selection process for the essential psychiatric medicines in the public system coverage list of Brazilian communities (cities) and the use of the target drugs. Municipal health secretaries were interviewed regarding the selection process for REMUMEs and the antidepressants and benzodiazepines included in REMUMEs and reference lists. We calculated the use of REMUME drugs that appeared or did not appear on reference lists according to the defined daily dose (DDD) per 10,000 inhabitants. Local physicians and pharmacists without specific training or explicit criteria developed the REMUMEs. Of the 13 drugs and 24 products (i.e., the different dosages of these 13 drugs) in the REMUMEs, 8 dr...Continue Reading

References

Jan 1, 1991·Journal of Substance Abuse Treatment·M Lader
Jan 29, 2002·Current Pharmaceutical Design·A N Bateson
Jan 21, 2004·CNS Drugs·Melinda J BarkerSimon F Crowe
Mar 9, 2004·Journal of Psychiatric Research·Dalva PoyaresSergio Tufik
Jan 10, 2006·Revista latino-americana de enfermagem·Paula Orlandi, Ana Regina Noto
Feb 9, 2007·Pharmacoepidemiology and Drug Safety·Ryne Paulose-RamDenise Orwig
Apr 7, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·I-Chia ChienPesus Chou
Dec 21, 2007·São Paulo Medical Journal = Revista Paulista De Medicina·Carmen Sylvia RibeiroNeury José Botega
Jan 9, 2008·Pharmacoepidemiology and Drug Safety·Alesha J SmithSusan E Tett
Jun 1, 2010·Cadernos de saúde pública·Tatiane da Silva Dal PizzolMaria Beatriz Cardoso Ferreira
Jan 12, 2011·British Journal of Clinical Pharmacology·Leonie MantheyFrans G Zitman
Aug 1, 2012·Epidemiology and Psychiatric Sciences·M Purgato, C Barbui
Dec 18, 2012·Psychiatric Services : a Journal of the American Psychiatric Association·Pierre-Alexandre DionneMichel Preville
Jul 2, 2014·Psychiatric Services : a Journal of the American Psychiatric Association·Maria Rosaria GualanoRoberta Siliquini
Dec 9, 2014·CMAJ Open·Silvia Alessi-SeveriniJitender Sareen

❮ Previous
Next ❯

Citations

Aug 28, 2020·Frontiers in Pharmacology·Luciane Cruz LopesMarcus Tolentino Silva
Feb 12, 2021·Health Policy and Planning·Walter Denis OdochBerit Sofie Hustad Hembre
May 19, 2020·Pharmacoepidemiology and Drug Safety·Maribel SalasUlf Bergman

❮ Previous
Next ❯

Software Mentioned

REMUME

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cadernos de saúde pública
Tatiane da Silva Dal PizzolMaria Beatriz Cardoso Ferreira
International Perspectives on Sexual and Reproductive Health
Jane HutchingsKathleen Donnelly
© 2022 Meta ULC. All rights reserved